[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help] 

Status: Not Logged In; Sign In

Israel knew October 7th was going to happen

One of the World’s Richest Men is Moving to America After Trump’s Landslide Victory

Taiwan has a better voting system than America

Donald Trump on Tuesday nominated veteran, author, and Fox News host Pete Hegseth as the Secretary of Defense

"Warrior For Truth & Honesty" - Trump Names John Ratcliffe As CIA Director

"The Manhattan Project" Of Our Time: Musk And Vivek Ramaswamy To Head Department Of Government Efficiency (DOGE)

Trump, Rogan and French Fries at MsDonalds

President Trump wants a 10% cap on all credit card interest rates

Senator Ted Cruz STUNS the Entire Congress With This POWERFUL Speech (On the Border)

Kash Patel, Trump’s top choice for CIA Director, wants to immediately release classified

The £4 supplement that could slash blood pressure - reducing stroke, dementia and heart attack risk

RFK Jr. to be involved in oversight of health and agriculture departments under second Trump admin

​​​​​​​"Keep Grinding": Elon Musk's America PAC Will Continue Anti-Soros Push Ahead Of Special Elections & Midterms

Johnny B Goode

Russian Hypersonic Advances Remain Beyond Western Reach

US Preps for War vs China, Dusts-Off Deserted WWII Air Bases

Spain on high alert as deadly storms loom: new flood risks in Barcelona, Majorca, Ibiza.

U.S. Publication Foreign Policy Says NATO Knows Ukraine Is Losing The War

Red Lobster and TGI Fridays are closing. Heres whats moving in

The United Nations is again warning of imminent famine in northern Gaza.

Israeli Drone Attack Targets Aid Distribution Center in Syria

Trump's new Cabinet picks, a Homan tribute, and Lizzo's giant toddler hand [Livestream in progress]

Russia and Iran Officially Link Their National Banking Systems

"They Just Got Handed Fraudulent Books" - Ed Dowd Confirms Our Warning That Trump Is 'Inheriting A Turd Of An Economy'

They're Getting Worse! 😂

'Forever Chemicals' In US Drinking Water: A Growing Problem

Ex-Trump aides warn Israeli ministers not to assume hell back annexation in 2nd term

Netanyahu seeks to delay taking the stand, citing lack of time to prepare during war

Google inadvertently reveals Kiev regimes aircraft stationed, operating from Poland

Taiwan Mulls Massive $15BN Arms Package To Signal Trump It's 'Serious' About Defense


Science/Tech
See other Science/Tech Articles

Title: Scientists grow drug for rare disease in corn
Source: [None]
URL Source: http://www.newsdaily.com/stories/bre88h0z9-us-corn-medicine/
Published: Sep 19, 2012
Author: Ben Hirschler
Post Date: 2012-09-19 06:05:22 by Tatarewicz
Keywords: None
Views: 11

LONDON, Sep. 18, 2012 (Reuters) — Scientists have grown a drug to treat a rare genetic disease inside corn plants, potentially offering a cheaper way to manufacture a treatment that currently costs hundreds of thousands of dollars a year for each patient.

The move marks an advance for the emerging field of molecular farming, which could one day see complex biotech medicines being mass-produced in plants rather than factories.

Researchers from Canada and Australia reported on Tuesday that they had created transgenic corn that could synthesize alpha-L-iduronidase, an enzyme used for a debilitating condition called mucopolysaccharidosis I (MPS I).

The disease causes progressive damage to the heart, brain, and other organs.

The research is still at an early stage and the new plant-grown medicine has not been tested in clinical trials, so any eventual treatment is still many years from reaching the market.

But the work, led by scientists at Canada's Simon Fraser University, is a significant step forward because it shows a way of producing molecules that should be accepted by the human immune system without causing dangerous side effects.

George Lomonossoff of Britain's John Innes Centre, who was not involved in the research, said the ability to control the way sugars bound to proteins in the corn was "an important addition to the toolkit for producing pharmaceuticals in plants".

"This is GM technology which offers a means for the production of a better quality pharmaceutical. However, the clinical efficacy and safety of the drug will need to be proven," he said.

MPS I is one of dozens of lysosomal storage disorders, including Fabry and Gaucher disease, many of which can be treated with enzyme replacement therapies, made by companies like Sanofi's Genzyme unit and Shire.

But the current process of making them in mammalian cell cultures inside stainless steel tanks is very expensive.

In the case of MPS I, treatment with the enzyme replacement drug Aldurazyme, from Genzyme and Biomarin, costs over $300,000 a year for children and more for adults.

Writing in the journal Nature Communications, the researchers said transgenic plants could be a cost-effective and safe alternative.

Some large companies have been looking at ways to make complex protein drugs in plants but molecular farming has yet to deliver its first commercial product.

The closest is a Gaucher disease drug from Israel's Protalix BioTherapeutics and Pfizer, which is produced in a culture of carrot cells - rather than in whole plants - and was approved for sale in the United States in May.

(Reporting by Ben Hirschler; Editing by Louise Heavens)

Post Comment   Private Reply   Ignore Thread  



[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help]